Trials / Sponsors / EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection Healthy Subjects | Phase 1 | 2024-01-24 |
| Completed | Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | 2023-10-12 |
| Completed | UP-818-CC Injection in Healthy Chinese Subjects Healthy Subjects | Phase 1 | 2022-02-14 |